Heparin-Releasable Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (Tfpi) is Increased in the Coronary Circulation After Coronary Spasm in Patients with Coronary Spastic Angina - Evidence for association with and regulation by LDL in human plasma

By Nishiyama K.   Ogawa H.   Yasue H.   Soejima H.   Misumi K.   Kugiyama K.   Tsuji I.   Kumeda K.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction - Proposed heparin recognition region

By Ye Z.   Takano R.   Hayashi K.   Ta T.-V.   Kato H.   Kamikubo Y.   Nakahara Y.   Kumeda K.   Hara S.  

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis

By Cella G.   Vianello A.   Rampin E.   Sbarai A.   Boeri G.   Vertolli U.   Naso A.   Strauss W.E.  

Thrombosis Research, Vol. 81, Iss. 6, 1996-03 ,pp. : 671-677

Elsevier

Access to resources Recommend Favorite

Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders

By Ozcan M.A.   Comlekci A.   Demirkan F.   Yuksel F.   Sari I.   Demir T.   Ozsan G.H.   Oruk G.   Yesil S.   Undar B.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite

Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients

By Gando S.   Kameue T.   Matsuda N.   Hayakawa M.   Morimoto Y.   Ishitani T.   Kemmotsu O.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite